167 related articles for article (PubMed ID: 12495466)
21. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk.
Wu X; Yu H; Amos CI; Hong WK; Spitz MR
J Natl Cancer Inst; 2000 May; 92(9):737-43. PubMed ID: 10793110
[TBL] [Abstract][Full Text] [Related]
22. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden.
Palmqvist R; Hallmans G; Rinaldi S; Biessy C; Stenling R; Riboli E; Kaaks R
Gut; 2002 May; 50(5):642-6. PubMed ID: 11950809
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers.
Stolzenberg-Solomon RZ; Limburg P; Pollak M; Taylor PR; Virtamo J; Albanes D
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):438-44. PubMed ID: 15006921
[TBL] [Abstract][Full Text] [Related]
25. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
[TBL] [Abstract][Full Text] [Related]
26. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
Drogan D; Schulze MB; Boeing H; Pischon T
Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
[TBL] [Abstract][Full Text] [Related]
27. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
[TBL] [Abstract][Full Text] [Related]
28. [Significance and expression of insulin-like growth factor 1 and IGF binding protein 3 in serum of patients with lung cancer].
Wang H; Wan YX; Zhang QK
Ai Zheng; 2004 Jun; 23(6):710-4. PubMed ID: 15191678
[TBL] [Abstract][Full Text] [Related]
29. Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States).
Li L; Yu H; Schumacher F; Casey G; Witte JS
Cancer Causes Control; 2003 Oct; 14(8):721-6. PubMed ID: 14674736
[TBL] [Abstract][Full Text] [Related]
30. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
[TBL] [Abstract][Full Text] [Related]
31. A nested case-control study of stomach cancer and serum insulin-like growth factor (IGF)-1, IGF-2 and IGF-binding protein (IGFBP)-3.
Pham TM; Fujino Y; Kikuchi S; Tamakoshi A; Yatsuya H; Matsuda S; Yoshimura T;
Eur J Cancer; 2007 Jul; 43(10):1611-6. PubMed ID: 17532620
[TBL] [Abstract][Full Text] [Related]
32. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
Oh JC; Wu W; Tortolero-Luna G; Broaddus R; Gershenson DM; Burke TW; Schmandt R; Lu KH
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):748-52. PubMed ID: 15159305
[TBL] [Abstract][Full Text] [Related]
33. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
[TBL] [Abstract][Full Text] [Related]
34. Serum insulin-like growth factor-I and breast cancer.
Toniolo P; Bruning PF; Akhmedkhanov A; Bonfrer JM; Koenig KL; Lukanova A; Shore RE; Zeleniuch-Jacquotte A
Int J Cancer; 2000 Dec; 88(5):828-32. PubMed ID: 11072255
[TBL] [Abstract][Full Text] [Related]
35. The Prospective Association Between Plasma Concentrations of Cellular Growth Factors and Risk of Heart Failure Mortality in Japanese Population.
Eshak ES; Maruyama K; Iso H; Tamakoshi A
J Epidemiol; 2019 Mar; 29(3):104-109. PubMed ID: 30078811
[TBL] [Abstract][Full Text] [Related]
36. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Int J Cancer; 2007 May; 120(9):2007-12. PubMed ID: 17266031
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix.
Wu X; Tortolero-Luna G; Zhao H; Phatak D; Spitz MR; Follen M
Clin Cancer Res; 2003 Aug; 9(9):3356-61. PubMed ID: 12960122
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.
Chan JM; Stampfer MJ; Ma J; Gann P; Gaziano JM; Pollak M; Giovannucci E
J Natl Cancer Inst; 2002 Jul; 94(14):1099-106. PubMed ID: 12122101
[TBL] [Abstract][Full Text] [Related]
39. A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial.
Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Czernichow S; Hercberg S
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2269-72. PubMed ID: 16172243
[TBL] [Abstract][Full Text] [Related]
40. Associations of Insulin and IGFBP-3 with Lung Cancer Susceptibility in Current Smokers.
Ho GYF; Zheng SL; Cushman M; Perez-Soler R; Kim M; Xue X; Wang T; Schlecht NF; Tinker L; Rohan TE; Wassertheil-Smoller S; Wallace R; Chen C; Xu J; Yu H
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 27071409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
